Teva Pharmaceuticals USA recalls PIO&METFORMIN 15/1000 mg Tab 1 (Pioglitazone and Metformin XT) tablets, Takeda Brand Name: Actoplus Met XR (Pioglitazone

Recalled October 31, 2018 · FDA recall D-0102-2019 · Teva Pharmaceuticals USA

Hazard

Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release. · FDA Class II

Units

N/A

Sold at

Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.

Description

Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Product

PIO&METFORMIN 15/1000 mg Tab 1 (Pioglitazone and Metformin XT) tablets, Takeda Brand Name: Actoplus Met XR (Pioglitazone and metformin HCl extended -release) tablets, 15 mg/1000 mg, packaged in a fiber drum, Application Holder Takeda Pharmaceuticals, U.S.A. Inc. One Takeda Parkway, Deerfield, IL 60015

Manufacturer(s)

Teva Pharmaceuticals USA

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →